Table 2 Demographic, clinical and optical coherence tomography (OCT) finding comparisons at the time of treatment advice between the two study groups:
Early treatment group | Delayed treatment group | P value | |
|---|---|---|---|
No of eyes (n) | 94 | 15 | |
No. of patients (n) | 81 | 12 | |
Males: Females (n) | 63:18 | 9:3 | > 0.999 |
Age (years) | 65.93 ± 9.134 | 62.20 ± 9.536 | 0.148 |
Duration of DM (years) | 16.99 ± 8.29 | 15.40 ± 5.06 | 0.795 |
HbA1c (%) | 8.453 ± 1.03 | 8.213 ± 0.621 | 0.565 |
Moderate NPDR (n, %) | 18 (20) | 8 (53) | 0.008 |
Severe NPDR (n, %) | 38 (40) | 0 (0) | 0.001 |
PDR (n, %) | 38 (40) | 7 (47) | 0.779 |
Visual acuity (ETDRS letters) | 50.05 ± 12.1 | 58.23 ± 11.1 | 0.314 |
Central subfield thickness (microns) | 527.2 ± 143.7 | 445.3 ± 107.8 | 0.036 |
Average time interval between recommending treatment and receiving treatment (weeks) | 2.237 ± 3.607 | 31.24 ± 7.456 |